Reporting Manager
Gilde Healthcare Holding B.V.
Shares outstanding
33,295,479 shares
Disclosed Ownership
2,187,513 shares
Ownership
6.6%
Form type
SCHEDULE 13D
Filing time
13 Feb 2026, 16:05:01 UTC
Date of event
09 Feb 2026

Sponsored

Quoteable Key Fact

"Gilde Healthcare Holding B.V. disclosed 6.6% ownership in SpyGlass Pharma, Inc. Common Stock, par value $0.00001 per share on 09 Feb 2026."

Quick Takeaways

  • Gilde Healthcare Holding B.V. filed SCHEDULE 13D for SpyGlass Pharma, Inc. Common Stock, par value $0.00001 per share.
  • Disclosed ownership: 6.6%.
  • Date of event: 09 Feb 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 13 Feb 2026, 16:05.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Gilde Healthcare Holding B.V. 6.6% 2,187,513 0 2,187,513 /s/ Edwin de Graaf Edwin de Graaf/Managing Director 0001420106
Gilde Healthcare VG VI Management B.V. 6.6% 2,187,513 0 2,187,513 /s/ Edwin de Graaf Edwin de Graaf/Managing Director
Cooperatieve Gilde Healthcare VG VI U.A. 6.6% 2,187,513 0 2,187,513 /s/ Edwin de Graaf Edwin de Graaf/Managing Director of Gilde Healthcare VG VI Management B.V., as Manager of Cooperatieve Gilde Healthcare VG VI U.A.
Manapouri B.V. 6.6% 2,187,513 0 2,187,513 /s/ Edwin de Graaf Edwin de Graaf/Managing Director
Martemanshurk B.V. 6.6% 2,187,513 0 2,187,513 /s/ Pieter van der Meer Pieter van der Meer/Managing Director